CINECA IRIS Institutional Research Information System

BASOLO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.390
EU - Europa 11.443
AS - Asia 4.311
AF - Africa 535
SA - Sud America 54
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 39.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.828
IT - Italia 3.636
SE - Svezia 2.469
CN - Cina 2.034
DE - Germania 1.850
BG - Bulgaria 1.099
SG - Singapore 813
GB - Regno Unito 644
TR - Turchia 565
CA - Canada 554
VN - Vietnam 425
AT - Austria 406
FI - Finlandia 379
UA - Ucraina 364
CI - Costa d'Avorio 317
HK - Hong Kong 236
RU - Federazione Russa 158
SN - Senegal 145
IN - India 136
CH - Svizzera 133
BE - Belgio 80
FR - Francia 75
BR - Brasile 40
NG - Nigeria 40
NL - Olanda 32
IR - Iran 20
PL - Polonia 18
AU - Australia 16
CZ - Repubblica Ceca 16
BJ - Benin 15
ES - Italia 15
JP - Giappone 15
KR - Corea 15
EU - Europa 14
RO - Romania 14
GR - Grecia 9
JO - Giordania 7
MA - Marocco 7
RS - Serbia 7
ID - Indonesia 6
IE - Irlanda 6
MY - Malesia 6
PK - Pakistan 6
DK - Danimarca 5
EG - Egitto 5
IL - Israele 5
CL - Cile 4
EC - Ecuador 4
HU - Ungheria 4
SA - Arabia Saudita 4
TW - Taiwan 4
CY - Cipro 3
PT - Portogallo 3
AR - Argentina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
EE - Estonia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LU - Lussemburgo 2
MT - Malta 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BO - Bolivia 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
IM - Isola di Man 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MS - Montserrat 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 39.765
Salva come PNG Salva come JPEG
Città #
Fairfield 3.028
Woodbridge 2.474
Chandler 2.182
Houston 1.793
Ann Arbor 1.627
Ashburn 1.550
Seattle 1.276
Wilmington 1.119
Sofia 1.097
Cambridge 1.008
Beijing 718
New York 690
Milan 655
Ottawa 516
Izmir 507
Boardman 505
Serra 499
Princeton 486
Lawrence 443
Jacksonville 435
Medford 393
Singapore 384
Vienna 372
Abidjan 317
Nanjing 314
Des Moines 257
Pisa 233
Florence 228
San Diego 199
Dearborn 189
Dong Ket 147
London 146
Dakar 145
Hong Kong 131
Frankfurt am Main 125
Rome 123
Bern 115
Nanchang 115
Bremen 114
Boulder 93
Falls Church 91
Ogden 90
Kunming 87
Shanghai 77
Brussels 75
Jüchen 68
Lancaster 68
Shenyang 64
Redwood City 63
Los Angeles 56
Changsha 54
Hebei 54
Washington 48
Naples 47
Nürnberg 46
Fuzhou 45
Hefei 45
Norwalk 45
Dallas 43
Tianjin 43
Jiaxing 40
Lagos 39
Pune 39
Bologna 37
Quanzhou 36
Munich 35
Redmond 33
Hangzhou 30
Jinan 30
Orange 28
Guangzhou 27
Düsseldorf 26
Chicago 23
Kocaeli 23
Marseille 23
Vicopisano 23
San Francisco 21
Auburn Hills 20
Phoenix 20
Zhengzhou 20
Indiana 19
Verona 19
Seacroft 18
Fremont 16
Helsinki 16
Hyderabad 16
Kent 16
Tappahannock 16
Wuhan 16
Cotonou 15
Istanbul 15
Lanzhou 14
Toronto 14
Detroit 13
Lucca 13
Palermo 13
Trieste 13
Turin 13
Chengdu 12
Zurich 12
Totale 28.829
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 828
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 259
null 259
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 202
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 196
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 189
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 186
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 185
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 183
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 168
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 163
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 162
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 161
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 161
null 160
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 160
null 157
Picornavirus-induced immuno-suppression 156
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 153
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 152
Surgical treatment of pleural recurrence from thymoma 151
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 148
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 147
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 146
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 146
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 145
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 142
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 142
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 141
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 139
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 139
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 138
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 137
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 136
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 135
A proteomic approach to study parathyroid glands 135
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 134
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 134
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 134
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 133
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 133
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 132
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 128
DIABETES MELLITUS 126
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 126
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 125
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 125
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 124
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 124
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 124
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 123
null 122
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 122
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 122
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 121
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 121
miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas 120
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 120
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 119
Influence of T and N stages on long term survival in resectable small cell lung cancer 118
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer 118
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 117
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 117
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 117
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 116
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 116
Intimal Sarcoma of the Descending Aorta Mimicking Aortitis 116
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 115
Ectopic expression of bone sialoprotein in human thyroid cancer 115
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 115
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 115
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 115
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 114
null 114
A microRNA signature for the differential diagnosis of salivary gland tumors 113
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 112
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 112
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 112
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 111
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 110
null 110
The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology 110
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 110
Lipomatous hamartoma-like lesion of a bicuspid aortic valve: an incidental surgical finding 109
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 109
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 108
A HUMAN MONOCLONAL AUTOANTIBODY ISOLATED FROM A PATIENT WITH INFECTIOUS-MONONUCLEOSIS REACTIVE WITH BOTH SELF ANTIGENS AND EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN (EBNA) 108
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 108
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 108
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 108
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 108
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 107
KRAS and BRAF mutational analyses in a phase II trial of first-line folfoxiri plus bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients (pts) 107
Plasma and tissue chromogranin in patients with adrenocortical adenomas 107
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 107
Cancer prevalence in follicular thyroid nodules. Need for surgery and role of intraoperative frozen section analysis 107
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 107
Role of YAP-1 in Thyroid Tumor Progression and Outcome 107
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 107
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 107
Totale 13.966
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.948 0 0 0 520 807 900 926 663 775 544 649 164
2020/20213.654 298 246 235 184 370 189 294 386 354 317 234 547
2021/20225.364 124 221 151 396 995 831 163 236 282 264 293 1.408
2022/20237.123 893 961 516 643 756 892 101 578 1.202 64 438 79
2023/20244.486 477 417 484 361 638 841 191 157 145 116 180 479
2024/20251.267 125 575 154 413 0 0 0 0 0 0 0 0
Totale 40.617